# China NMPA Drug Inspection - Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co., Ltd. - Irbesartan tablets

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/yangtze-river-pharmaceutical-group-jiangsu-zilong-pharmaceutical-co-ltd/b3c0f1f4-b07a-4449-95a7-80266056a020/
Source feed: China

> China NMPA drug inspection for Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co., Ltd. published September 21, 2018. Drug: Irbesartan tablets. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Jiangxi Province 2018 Drug Quality Bulletin
- Company Name: Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co., Ltd.
- Publication Date: 2018-09-21
- Drug Name: Irbesartan tablets

Company: https://www.globalkeysolutions.net/companies/yangtze-river-pharmaceutical-group-jiangsu-zilong-pharmaceutical-co-ltd/3b951c88-7114-46ab-a549-52c02d5c24c0/